Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Liabilities and Shareholders Equity (2019 - 2025)

Pulmonx (LUNG) has disclosed Liabilities and Shareholders Equity for 7 consecutive years, with $138.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 17.4% to $138.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $448.3 million, a 34.3% decrease, with the full-year FY2024 number at $162.8 million, down 8.4% from a year prior.
  • Liabilities and Shareholders Equity was $138.3 million for Q3 2025 at Pulmonx, down from $147.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $255.3 million in Q1 2021 to a low of $138.3 million in Q3 2025.
  • A 5-year average of $189.6 million and a median of $185.0 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 246.44% in 2021, then fell 18.23% in 2024.
  • Pulmonx's Liabilities and Shareholders Equity stood at $235.2 million in 2021, then decreased by 17.65% to $193.7 million in 2022, then decreased by 8.21% to $177.8 million in 2023, then dropped by 8.4% to $162.8 million in 2024, then dropped by 15.09% to $138.3 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Liabilities and Shareholders Equity are $138.3 million (Q3 2025), $147.2 million (Q2 2025), and $162.8 million (Q4 2024).